首页> 外文期刊>Indian drugs >DESIGN, SYNTHESIS AND EVALUATION OF 6-SUBSTITUTED-4-HYDROXY-1-(2-SUBSTITUTEDACETYL)-3-NITROQUINOLIN-2(1H)-ONES FOR ANTICANCER ACTIVITY
【24h】

DESIGN, SYNTHESIS AND EVALUATION OF 6-SUBSTITUTED-4-HYDROXY-1-(2-SUBSTITUTEDACETYL)-3-NITROQUINOLIN-2(1H)-ONES FOR ANTICANCER ACTIVITY

机译:6取代-4-羟基-1-(2-取代基)-3-硝基喹啉-2(1H)抗癌活性的设计,合成和评价

获取原文
获取原文并翻译 | 示例
           

摘要

The present work deals with the synthesis of a series of 6-substituted-4-hydroxy-1-(2-substitued alicyclicaminoacetyl)-3-nitroquinolin-2(1H)-one {IVa-d (1-3)} derivatives and evaluation of their in vitro anticancer activity. Docking study was carried out using EGFR-tyrosine kinase binding site (PDB ID: 1m17) and revealed encouraging results. The sequence of reactions consists of the initial synthesis of 6-substituted 4-hydroxyquinolin-2( 1 H)-ones (la-d), which were further subjected to nitration reaction to give 6- substituted-4-hydroxy-3-nitroquinolin-2(1H)-one (lla-d). Condensation of compounds (lla-d) with chloroacetyl chloride resulted in 6-substituted-1-(2-chloroacetyl)-4-hydroxy-3-nitroquinolin-2(1H)-one (Illa-d), which was subjected to substitution reaction using various secondary amines to yield the title compounds {IVa-d (1-3)}. All the synthesized compounds were characterized by IR, NMR and mass spectral data.AII the derivatives were tested for their in vitro anticancer activity using KB (oral cancer) cell lines. Among the synthesized compounds, compound (IVc-2) was found to be the most cytotoxic as compared to the other synthesized derivatives, with IC_(50) values of 0.2406uM/mL against KB cell line.
机译:本作工作涉及一系列6取代-4-羟基-1-(2级替代的alicclic氨基乙酰基)-3-硝基喹啉-2(1H) - ON {IVA-D(1-3)}衍生物和评估其体外抗癌活动。使用EGFR-酪氨酸激酶结合位点进行对接研究(PDB ID:1M17),并揭示了令人鼓舞的结果。反应序列由初始合成6取代的4-羟基喹啉-2(1小时) - 酮(La-D),其进一步进行硝化反应,得到6-取代-4-羟基-3-硝基喹啉-2(1H) - 酮(LLA-D)。化合物(LLA-D)与氯乙酰氯的缩合产生6-取代的-1-(2-氯乙酰基)-4-羟基-3-硝基喹啉-2(1H) - ONE(ILLA-D),其进行取代使用各种仲胺的反应产生标题化合物(IVA-D(1-3)}。所有合成的化合物的特征在于IR,NMR和质谱数据,使用KB(口腔癌)细胞系来测试衍生物的体外抗癌活性。在合成化合物中,发现与其他合成衍生物相比的化合物(IVC-2)是最多的细胞毒性,IC_(50)值为0.2406um / ml对Kb细胞系相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号